000			02308 a2200709 4500
005			20250516040805.0
264		0	_c20111207
008			201112s 0 0 eng d
022			_a1873-7560
024	7		_a10.1016/j.eururo.2011.05.028 _2doi
040			_aNLM _beng _cNLM
100	1		_aPowles, Thomas
245	0	0	_aThe outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. _h[electronic resource]
260			_bEuropean urology _cSep 2011
300			_a448-54 p. _bdigital
500			_aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIndoles _xadministration & dosage
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNephrectomy _xadverse effects
650	0	4	_aPatient Selection
650	0	4	_aProportional Hazards Models
650	0	4	_aProspective Studies
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aPyrroles _xadministration & dosage
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSunitinib
650	0	4	_aSurvival Rate
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aBlank, Christian
700	1		_aChowdhury, Simon
700	1		_aHorenblas, Simon
700	1		_aPeters, John
700	1		_aShamash, Jonathan
700	1		_aSarwar, Naveed
700	1		_aBoleti, Ekaterini
700	1		_aSahdev, Anju
700	1		_aO'Brien, Tim
700	1		_aBerney, Dan
700	1		_aBeltran, Luis
700	1		_aNathan, Paul
700	1		_aHaanen, John
700	1		_aBex, Axel
773	0		_tEuropean urology _gvol. 60 _gno. 3 _gp. 448-54
856	4	0	_uhttps://doi.org/10.1016/j.eururo.2011.05.028 _zAvailable from publisher's website
999			_c20873669 _d20873669